Healthcare
Wednesday, September 21, 2016
BRIEF-BioMarin reviews status of Exon 51 composition of matter
* To seek review of patent trial and appeal board ruling,
for composition of matter claims related to exon 51 skipping
antisense oligonucleotides
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment